but the benefit is unclear Spironolactone is also an ideal add-on agent American College of Cardiology/American Heart Association classification of heart failure. ACE-I = Angiotensin converting ...

Secondary outcomes: NYHA class improvement: 15.0% in the sacubitril/valsartan ... in Women Compared to Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF. Circulation ...

You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.

We read every piece of feedback, and take your input very seriously.

As academic director for Duke University's corporate education business, Cheryl Stokes traveled the globe. Doing so while 4 months pregnant meant enduring more discomfort than usual.

Our vision is to innovate and incorporate promising technologies to communicate freely available, high-priority, high-quality content, which accelerates scientific progress and advances heart and ...

DEAR DR. ROACH: My husband is 73 and was diagnosed with heart failure and a severely dilated left ventricle. At the time, he was pumping 10 liters per minute. He had a proBNP natriuretic peptide ...

CORXEL (formerly Ji Xing) acquired the rights to develop and commercialize aficamten in Greater China (including the Chinese ...

uhn.ca Objective To develop new classification criteria for systemic lupus erythematosus (SLE) jointly supported by the European League Against Rheumatism (EULAR) and the American College of ...

Medical Staff Hospital Cardiologists Studies have shown that HF outcomes are better for patients when they are admitted under specialist cardiology medical staff. [22,23] This is a crucial high ...

The following are key points to remember from a review on aortic stenosis (AS), heart failure (HF), and aortic valve replacement (AVR): AS is responsible for the development of HF that is mediated ...

New Gene Therapy Reverses Heart Failure in Large Animal Model Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart ...